NeuroBionics raises cash, names CEO (Chief Executive Officer):
This article was originally published in Clinica
A company working on closed-loop neuromodulation devices to treat neurological disorders like Parkinson's disease and epilepsy has completed a $6m financing round and named serial medtech entrepreneur John Harris as president and CEO. NeuroBionics, of Seattle, received funding from The Sprout Group and Three Arch Partners, which respectively nominated partners Andrew Firlik and Bill Harrington to its board of directors. Mr Harris is a founder of two other Seattle-based medical device firms: Northstar Neuroscience (electrical brain stimulation technology for stroke recovery) and Heartstream (public-access heart defibrillators).
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.